Potential Efficacy of Anti-PD-1 or PD-L1 Antibody Treatments for Gynecologic Cancers
Journal Title: Women's Health – Open Journal - Year 2017, Vol 3, Issue 3
Abstract
Programmed cell death-1 (PD-1; CD279) is an immunosuppressive co-inhibitory molecule that belongs to the CD28 family of receptors on T-cells. It was discovered by Ishida et al in 1992.1 The most important peripheral regulatory pathway is the interaction between the PD-1 receptor, expressed on T-cells, and programmed cell death ligands-1 and 2 (PD-L1 and PD-L2) on the cancer cell surface.2 This immune checkpoint exists in a normal physiological state to protect against autoimmunity and inflammation. In a neoplastic state, dysfunction of these immune checkpoint proteins can lead to tumor tolerance and eventually allow tumors to ‘escape’ from the immune system. PD-1 blockage enhances the proliferation of transferred T-cells at the tumor site. In addition, the combination of adoptive T-cell transfer and anti-PD-1 antibody results in significant inhibition of tumor progression.3 These therapeutic effects of PD-1 blockage require the INF-γ signal. Targeting the molecules that regulate the immune response using the new drug nivolumab, an anti-PD-1 antibody has been the subject of much research and has yielded some promising and exciting results.
Authors and Affiliations
Masafumi Koshiyama
Keywords
Related Articles
- EP ID EP554947
- DOI 10.17140/WHOJ-3-e013
- Views 159
- Downloads 0
What Women Should Know About Alcohol Abuse and the Sexual Exploitation of Females of all Ages (Part 3)
The aim of this paper is to raise our level of awareness on the egregious blight which alcohol abuse has afflicted upon the United States. Given the limitations of space, I shall divide the topic into two specific areas...
Towards Increasing Contraceptive Prevalence in Burkina Faso through Task Sharing
The prevalence of contraception in Burkina Faso (BF) has increased in the past 18 years from 5.8%1 in 1998 to 25%2 in 2016; an increase of 1% per year while population growth remains strong and stable at 3.1% per year. T...
Risk Factors and Barriers to Male Involvement in the Choice of Family Planning Methods in the Buea Health District, South West Region,Cameroon: A Cross-Sectional Study in a Semi-Urban Area
Background: Family Planning (FP) promotion and services are often focused on women, but nonetheless men have an important role to play also. Engaging men in family planning programs and services has the potential to impr...
Mixed Epithelial and Germ Cell Ovarian Cancer: A Case Report
Background: Cases of malignant ovarian tumors consisting of Clear Cell Carcinoma (CCC) and Yolk Sac Tumor (YST) are decidedly rare. Case: We herein report the case of a 58-year-old woman with an ovarian tumor, of which a...
From Menstruation to Menopause: Have We Medicalised the Physiology of Normalcy? (Part 1)
UNDERSTANDING THE RELATIONSHIP BETWEEN MENSTRUATION AND MENOPAUSE Although, there are exceptions to the rule, women generally experience ‘menopause’ between the ages of 48 to 54, within which time the cessation of all me...